BIOMAT Database Logo BIOMAT Database Logo

Lack of dependence and withdrawal symptoms in healthy volunteers given high doses of tybamate. 1967

J P Colmore, and J D Moore

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D014149 Tranquilizing Agents A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. Ataractics,Tranquilizing Drugs,Tranquilizing Effect,Tranquilizing Effects,Tranquillizing Agents,Tranquillizing Drugs,Agents, Tranquilizing,Agents, Tranquillizing,Drugs, Tranquilizing,Drugs, Tranquillizing,Effect, Tranquilizing,Effects, Tranquilizing

Related Publications

J P Colmore, and J D Moore
Lack of addiction from high doses of tybamate.
January 1966, The Journal of new drugs,
J P Colmore, and J D Moore
Lack of toxicity of folic acid given in pharmacological doses to healthy volunteers.
January 1971, Lancet (London, England),
J P Colmore, and J D Moore
Toxicity of folic acid given in pharmacological doses to healthy volunteers.
January 1970, Lancet (London, England),
J P Colmore, and J D Moore
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses.
November 1996, Antimicrobial agents and chemotherapy,
J P Colmore, and J D Moore
Tolerability of high doses of (-)-moprolol in healthy volunteers.
January 1982, European journal of clinical pharmacology,
J P Colmore, and J D Moore
Inhalant dependence and withdrawal symptoms.
June 2000, Journal of the American Academy of Child and Adolescent Psychiatry,
J P Colmore, and J D Moore
Pharmacokinetics of reboxetine in healthy volunteers. Single against repeated oral doses and lack of enzymatic alterations.
October 1996, Biopharmaceutics & drug disposition,
J P Colmore, and J D Moore
The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.
July 1986, British journal of clinical pharmacology,
J P Colmore, and J D Moore
Pharmacokinetics of oxatomide given percutaneously to healthy volunteers.
October 1992, Biopharmaceutics & drug disposition,
J P Colmore, and J D Moore
Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy.
July 2009, Gastroenterology,
Copied contents to your clipboard!